MassRoots User Growth is Putting the Emphasis on “Mass”

Spotlight Companies |

Cannabis-themed social media platform MassRoots (OTCQB:MSRT) announced Friday that it had rounded the 775,000 users figure as it builds momentum towards 1 million users, a milestone it anticipates hitting, fortuitously enough, just before 4/20 this year.

This comes on the heels of news that Facebook (FB) would be deleting the business pages for medical marijuana dispensaries, a sign that the leaders in social media appear to be behind the trend. With medical marijuana legal in 23 states, recreational use legal in four, and another dozen or states voting on the issue in November, the cultural shift away from stigmatizing cannabis use appears to be rapidly gaining momentum. The swift rate of user growth, in addition to Facebook’s draconian move, seems to only confirm the degree to which MassRoots is the social media platform existing on the leading edge of this change.

New Web Platform Proves a Success

MassRoots continues to see the majority of its growth driven by mobile users, a new web-based platform launched in December has been making rapid progress. A robust SEO strategy has traffic at the website taking off, as hit its highest ever Alexa Ranking, a public measure of a website’s visitors, on 21 of the 31 days in January.

MassRoots represents an intriguing “picks and shovels” approach to the burgeoning cannabis industry. While operating in areas of the industry that require actually handling and/or selling the cannabis plant can result in a tricky legal limbo between state and federal laws that can create major difficulties, MassRoots has built a platform that can grow with the industry and support its various players without having to engage directly.

For cannabis users both medical and recreational, having a single social media platform supporting their culture represents a major step in the right direction, facilitating communication between users as well as businesses and their customer base. People can openly discuss different products, and brands can collect much-needed feedback straight from the source.

Disclosure: In the purview of Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that, Inc. may be compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. is not a registered broker, broker dealer, investment advisor, analyst, investment banker or underwriter. All profiles are based on information that is available to the public. The information contained herein should not be considered to be all-inclusive and is not guaranteed by to be free from misstatement or errors. Readers are reminded to do their own due diligence when researching any companies mentioned on this website.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…


Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…